Press Releases

Diamyd Medical’s financial year comprises 1 September – 31 August.

Press Releases
1/21/2025 South Korea to grant precision medicine patent to Diamyd Medical for insulin antigen treatment in autoimmune diabetes
1/13/2025 Diamyd Medical updates U.S. market potential for Diamyd^®
1/10/2025 Diamyd Medical confirms key advances toward Accelerated Approval for Diamyd^® following FDA Type C Meeting
1/9/2025 Renowned immunology investigator, Alice Long, joins Diamyd Medical’s Scientific Advisory Board
1/7/2025 New publication highlights safety and potential benefits of redosing Diamyd^® precision medicine for Type 1 Diabetes

ORDER